Basal cell carcinoma

Michael P. McLeod, Sonal Choudhary, Yasser A. Alqubaisy, Keyvan Nouri

Research output: Chapter in Book/Report/Conference proceedingChapter

1 Citation (Scopus)

Abstract

BCC is the most common neoplasm encountered in humans. It is also the most common indication for Mohs micrographic surgery (MMS). MMS has a 99% 5-year cure rate for primary BCCs. For recurrent BCCs, the 5-year cure rate is 96%. Infiltrating, micronodular, and morpheaform subtypes are considered more aggressive forms of BCC, and MMS should be the primary treatment for those subtypes. Inflammatory cells, hair follicles, and folliculocentric basaloid proliferations are benign conditions that can resemble BCC when using horizontal frozen sections. Malignant processes such as metastatic breast cancer, ameloblastoma, cloacogenic carcinoma, eccrine spiradenoma, pilomatricomas, and trichoepitheliomas can also mimic BCC. Additionally, BCC may differentiate to simulate many structures such as hair follicles, sweat glands, and sebaceous glands. The evidence behind MMS for BCC is strong with studies backed by a high number of patients along with very low recurrence rates. It is especially well suited for aggressive histological subtypes of BCC and for BCCs in anatomical regions where tissue conservation is paramount.

Original languageEnglish (US)
Title of host publicationMohs Micrographic Surgery
PublisherSpringer-Verlag London Ltd
Pages177-188
Number of pages12
Volume9781447121527
ISBN (Print)9781447121527, 1447121511, 9781447121510
DOIs
StatePublished - Jun 1 2012

Fingerprint

Mohs Surgery
Basal Cell Carcinoma
Hair Follicle
Pilomatrixoma
Ameloblastoma
Sebaceous Glands
Sweat Glands
Frozen Sections
Breast Neoplasms
Recurrence
Neoplasms

Keywords

  • Basal cell carcinoma
  • Folliculocentric basaloid proliferations
  • Infiltrative BCC
  • Mohs micrographic surgery
  • Morpheaform BCC
  • Nodular BCC
  • Superficial BCC

ASJC Scopus subject areas

  • Medicine(all)

Cite this

McLeod, M. P., Choudhary, S., Alqubaisy, Y. A., & Nouri, K. (2012). Basal cell carcinoma. In Mohs Micrographic Surgery (Vol. 9781447121527, pp. 177-188). Springer-Verlag London Ltd. https://doi.org/10.1007/978-1-4471-2152-7_16

Basal cell carcinoma. / McLeod, Michael P.; Choudhary, Sonal; Alqubaisy, Yasser A.; Nouri, Keyvan.

Mohs Micrographic Surgery. Vol. 9781447121527 Springer-Verlag London Ltd, 2012. p. 177-188.

Research output: Chapter in Book/Report/Conference proceedingChapter

McLeod, MP, Choudhary, S, Alqubaisy, YA & Nouri, K 2012, Basal cell carcinoma. in Mohs Micrographic Surgery. vol. 9781447121527, Springer-Verlag London Ltd, pp. 177-188. https://doi.org/10.1007/978-1-4471-2152-7_16
McLeod MP, Choudhary S, Alqubaisy YA, Nouri K. Basal cell carcinoma. In Mohs Micrographic Surgery. Vol. 9781447121527. Springer-Verlag London Ltd. 2012. p. 177-188 https://doi.org/10.1007/978-1-4471-2152-7_16
McLeod, Michael P. ; Choudhary, Sonal ; Alqubaisy, Yasser A. ; Nouri, Keyvan. / Basal cell carcinoma. Mohs Micrographic Surgery. Vol. 9781447121527 Springer-Verlag London Ltd, 2012. pp. 177-188
@inbook{0776220e085f49f99ef1b269fa332827,
title = "Basal cell carcinoma",
abstract = "BCC is the most common neoplasm encountered in humans. It is also the most common indication for Mohs micrographic surgery (MMS). MMS has a 99{\%} 5-year cure rate for primary BCCs. For recurrent BCCs, the 5-year cure rate is 96{\%}. Infiltrating, micronodular, and morpheaform subtypes are considered more aggressive forms of BCC, and MMS should be the primary treatment for those subtypes. Inflammatory cells, hair follicles, and folliculocentric basaloid proliferations are benign conditions that can resemble BCC when using horizontal frozen sections. Malignant processes such as metastatic breast cancer, ameloblastoma, cloacogenic carcinoma, eccrine spiradenoma, pilomatricomas, and trichoepitheliomas can also mimic BCC. Additionally, BCC may differentiate to simulate many structures such as hair follicles, sweat glands, and sebaceous glands. The evidence behind MMS for BCC is strong with studies backed by a high number of patients along with very low recurrence rates. It is especially well suited for aggressive histological subtypes of BCC and for BCCs in anatomical regions where tissue conservation is paramount.",
keywords = "Basal cell carcinoma, Folliculocentric basaloid proliferations, Infiltrative BCC, Mohs micrographic surgery, Morpheaform BCC, Nodular BCC, Superficial BCC",
author = "McLeod, {Michael P.} and Sonal Choudhary and Alqubaisy, {Yasser A.} and Keyvan Nouri",
year = "2012",
month = "6",
day = "1",
doi = "10.1007/978-1-4471-2152-7_16",
language = "English (US)",
isbn = "9781447121527",
volume = "9781447121527",
pages = "177--188",
booktitle = "Mohs Micrographic Surgery",
publisher = "Springer-Verlag London Ltd",

}

TY - CHAP

T1 - Basal cell carcinoma

AU - McLeod, Michael P.

AU - Choudhary, Sonal

AU - Alqubaisy, Yasser A.

AU - Nouri, Keyvan

PY - 2012/6/1

Y1 - 2012/6/1

N2 - BCC is the most common neoplasm encountered in humans. It is also the most common indication for Mohs micrographic surgery (MMS). MMS has a 99% 5-year cure rate for primary BCCs. For recurrent BCCs, the 5-year cure rate is 96%. Infiltrating, micronodular, and morpheaform subtypes are considered more aggressive forms of BCC, and MMS should be the primary treatment for those subtypes. Inflammatory cells, hair follicles, and folliculocentric basaloid proliferations are benign conditions that can resemble BCC when using horizontal frozen sections. Malignant processes such as metastatic breast cancer, ameloblastoma, cloacogenic carcinoma, eccrine spiradenoma, pilomatricomas, and trichoepitheliomas can also mimic BCC. Additionally, BCC may differentiate to simulate many structures such as hair follicles, sweat glands, and sebaceous glands. The evidence behind MMS for BCC is strong with studies backed by a high number of patients along with very low recurrence rates. It is especially well suited for aggressive histological subtypes of BCC and for BCCs in anatomical regions where tissue conservation is paramount.

AB - BCC is the most common neoplasm encountered in humans. It is also the most common indication for Mohs micrographic surgery (MMS). MMS has a 99% 5-year cure rate for primary BCCs. For recurrent BCCs, the 5-year cure rate is 96%. Infiltrating, micronodular, and morpheaform subtypes are considered more aggressive forms of BCC, and MMS should be the primary treatment for those subtypes. Inflammatory cells, hair follicles, and folliculocentric basaloid proliferations are benign conditions that can resemble BCC when using horizontal frozen sections. Malignant processes such as metastatic breast cancer, ameloblastoma, cloacogenic carcinoma, eccrine spiradenoma, pilomatricomas, and trichoepitheliomas can also mimic BCC. Additionally, BCC may differentiate to simulate many structures such as hair follicles, sweat glands, and sebaceous glands. The evidence behind MMS for BCC is strong with studies backed by a high number of patients along with very low recurrence rates. It is especially well suited for aggressive histological subtypes of BCC and for BCCs in anatomical regions where tissue conservation is paramount.

KW - Basal cell carcinoma

KW - Folliculocentric basaloid proliferations

KW - Infiltrative BCC

KW - Mohs micrographic surgery

KW - Morpheaform BCC

KW - Nodular BCC

KW - Superficial BCC

UR - http://www.scopus.com/inward/record.url?scp=84949180399&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84949180399&partnerID=8YFLogxK

U2 - 10.1007/978-1-4471-2152-7_16

DO - 10.1007/978-1-4471-2152-7_16

M3 - Chapter

AN - SCOPUS:84949180399

SN - 9781447121527

SN - 1447121511

SN - 9781447121510

VL - 9781447121527

SP - 177

EP - 188

BT - Mohs Micrographic Surgery

PB - Springer-Verlag London Ltd

ER -